RhumbLine Advisers’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
|
|||||
|
2025
Q1 | $904K | Sell |
|
|||||
|
2024
Q4 | $1.34M | Buy |
|
|||||
|
2024
Q3 | $1.59M | Buy |
|
|||||
|
2024
Q2 | $1.22M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $113K | Sell |
|
|||||
|
2021
Q4 | $256K | Sell |
|
|||||
|
2021
Q3 | $430K | Buy |
|
|||||
|
2021
Q2 | $367K | Buy |
|
|||||
|
2021
Q1 | $367K | Sell |
|
|||||
|
2020
Q4 | $391K | Buy |
|
|||||
|
2020
Q3 | $321K | Sell |
|
|||||
|
2020
Q2 | $477K | Buy |
|
|||||
|
2020
Q1 | $177K | Buy |
|
|||||
|
2019
Q4 | $286K | Buy |
|
|||||
|
2019
Q3 | $287K | Buy |
|
|||||
|
2019
Q2 | $235K | Buy |
|
|||||
|
2019
Q1 | $194K | Buy |
|
|||||
|
2018
Q4 | $162K | Buy |
|
|||||
|
2018
Q3 | $139K | Sell |
|
|||||
|
2018
Q2 | $161K | Buy |
|